Oncocyte Corp CEO Ronald Andrews' 2022 pay slips 19% to $2.4M
Oncocyte Corp reports 2022 executive compensation
By ExecPay News
Published: May 19, 2023
Oncocyte Corp reported fiscal year 2022 executive compensation information on May 19, 2023.
In 2022, six executives at Oncocyte Corp received on average a compensation package of $1.1M, a 54% decrease compared to previous year.
Average pay of disclosed executives at Oncocyte Corp
Ronald Andrews, Chief Executive Officer, received $2.4M in total, which decreased by 19% compared to 2021. 32% of Andrews' compensation, or $746K, was in option awards. Andrews also received $460K in salary, $493K in stock awards, as well as $654K in other compensation.
Gisela Paulsen, Chief Operating Officer, received a compensation package of $1.3M. 38% of the compensation package, or $509K, was in stock awards.
Douglas Ross, Chief Scientific Officer, earned $1.1M in 2022, a 30% decrease compared to previous year.
Anish John, Chief Financial Officer, received $738K in 2022.
Joshua Riggs, Chief Executive Officer, earned $514K in 2022.
James Liu, Controller and Principal Accounting Officer, received $260K in 2022.
Related executives
Ronald Andrews
Oncocyte Corp
Chief Executive Officer
Gisela Paulsen
Oncocyte Corp
Chief Operating Officer
Douglas Ross
Oncocyte Corp
Chief Scientific Officer
Joshua Riggs
Oncocyte Corp
Chief Executive Officer
Anish John
Oncocyte Corp
Chief Financial Officer
James Liu
Oncocyte Corp
Controller and Principal Accounting Officer
You may also like
Source: SEC filing on May 19, 2023.